Literature DB >> 15365652

Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue.

Dionisios Mitropoulos1, Aspasia Kiroudi, Evangelia Christelli, Efraim Serafetinidis, Anastasios Zervas, Ioannis Anastasiou, Constantinos Dimopoulos.   

Abstract

TGFbeta1 is one of several cytokines produced by proximal tubular and renal cancer cells. Previous studies have been mainly focused on determining plasma or serum TGFbeta levels, its effect on RCC cultures, and the expression of TGFbeta mRNA. Cancerous and autologous normal kidney samples were obtained from 24 patients treated by radical nephrectomy. TGFbeta1 expression was determined using a semi quantitative Western blot analysis and immunohistochemistry. Blot densities and immunohistochemical expression intensities in normal and neoplastic tissue were compared, and subsequently correlated to tumor stage, histological type and nuclear grade. All tissue samples examined expressed TGFbeta1; mean tumor to non-involved kidney spot density ratio correlated with advancing stage and higher nuclear grade. The overexpression of TGFbeta1 in certain RCCs may partially explain their resistance to the growth suppression action of TGFbeta. The correlation with tumor stage and grade indicates a possible role in the development of metastatic potential as well as in host's immune response modulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365652     DOI: 10.1007/s00240-003-0360-z

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  37 in total

1.  Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.

Authors:  I Atlas; J Mendelsohn; J Baselga; W R Fair; H Masui; R Kumar
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

4.  Control of renal carcinoma TC-1 growth, cyclin/kinase and nm23 expression by IFN-gamma and TGF-beta.

Authors:  S Hall; T C Hsieh; C Y Ng; C Mallouh; J M Wu
Journal:  Anticancer Res       Date:  1996 Jul-Aug       Impact factor: 2.480

Review 5.  Tumor suppressor activity of the TGF-beta pathway in human cancers.

Authors:  S D Markowitz; A B Roberts
Journal:  Cytokine Growth Factor Rev       Date:  1996-06       Impact factor: 7.638

6.  Elevated plasma TGF-beta1 in renal diseases: cause or consequence?

Authors:  U Junker; C C Haufe; K Nuske; K Rebstock; T Steiner; H Wunderlich; K Junker; D Reinhold
Journal:  Cytokine       Date:  2000-07       Impact factor: 3.861

7.  Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.

Authors:  M R Cardillo; D Lazzereschi; O Gandini; F Di Silverio; G Colletta
Journal:  Anal Quant Cytol Histol       Date:  2001-04       Impact factor: 0.302

8.  Expression of cytokine mRNA transcripts in renal cell carcinoma.

Authors:  C Olive; C Cheung; D Nicol; M C Falk
Journal:  Immunol Cell Biol       Date:  1998-08       Impact factor: 5.126

9.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

10.  Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.

Authors:  S Sankar; N Mahooti-Brooks; L Bensen; T L McCarthy; M Centrella; J A Madri
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

View more
  18 in total

1.  Transforming growth factor-beta downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma.

Authors:  Cheryn Song; Sun-Young Jun; Jun-Hyuk Hong; Hanjong Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2007-02-06       Impact factor: 4.553

2.  Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.

Authors:  F Cabillic; F Bouet-Toussaint; O Toutirais; N Rioux-Leclercq; P Fergelot; C Thomas de la Pintière; N Genetet; J-J Patard; V Catros-Quemener
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

3.  Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.

Authors:  Zhiyuan Lou; Yi Yang; Tingting Ren; Shun Tang; Xianbo Peng; Qunshan Lu; Yifeng Sun; Wei Guo
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

Review 4.  The immunoregulatory mechanisms of carcinoma for its survival and development.

Authors:  Caigan Du; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2011-01-21

5.  The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma.

Authors:  Jonas Sjölund; Anna-Karin Boström; David Lindgren; Sugata Manna; Aristidis Moustakas; Börje Ljungberg; Martin Johansson; Erik Fredlund; Håkan Axelson
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

6.  The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression.

Authors:  Caroline Schroten; Natasja F Dits; Ewout W Steyerberg; Ries Kranse; Arno G J L H van Leenders; Chris H Bangma; Robert Kraaij
Journal:  Cancer Immunol Immunother       Date:  2011-11-24       Impact factor: 6.968

7.  TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.

Authors:  Yijie Chen; Lin Ma; Qian He; Shaobo Zhang; Chenghua Zhang; Wei Jia
Journal:  Biol Res       Date:  2015-05-21       Impact factor: 5.612

8.  Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.

Authors:  Ana L Teixeira; Francisca Dias; Marta Ferreira; Mónica Gomes; Juliana I Santos; Francisco Lobo; Joaquina Maurício; José Carlos Machado; Rui Medeiros
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.

Authors:  Mohammed I Khan; Anna M Czarnecka; Sławomir Lewicki; Igor Helbrecht; Klaudia Brodaczewska; Irena Koch; Robert Zdanowski; Magdalena Król; Cezary Szczylik
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

10.  Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cells.

Authors:  Lei Gao; Guo-jun Wu; Bei Liu; Ming-zhi Shen; Tie-jun Pan; Chui-gong Yu; Qin-hao Wang; Yi Ru; Xi-ping Liu; Tian-shui Niu; Guo-dong Wang; Ming Wei; Rui-xiao Li; Libo Yao; He Wang; Xia Li
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.